Remdesivir for the Treatment of Covid-19 — Final Report

BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:N Engl J Med
Hoofdauteurs: Beigel, John H., Tomashek, Kay M., Dodd, Lori E., Mehta, Aneesh K., Zingman, Barry S., Kalil, Andre C., Hohmann, Elizabeth, Chu, Helen Y., Luetkemeyer, Annie, Kline, Susan, Lopez de Castilla, Diego, Finberg, Robert W., Dierberg, Kerry, Tapson, Victor, Hsieh, Lanny, Patterson, Thomas F., Paredes, Roger, Sweeney, Daniel A., Short, William R., Touloumi, Giota, Lye, David Chien, Ohmagari, Norio, Oh, Myoung-don, Ruiz-Palacios, Guillermo M., Benfield, Thomas, Fätkenheuer, Gerd, Kortepeter, Mark G., Atmar, Robert L., Creech, C. Buddy, Lundgren, Jens, Babiker, Abdel G., Pett, Sarah, Neaton, James D., Burgess, Timothy H., Bonnett, Tyler, Green, Michelle, Makowski, Mat, Osinusi, Anu, Nayak, Seema, Lane, H. Clifford
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Massachusetts Medical Society 2020
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262788/
https://ncbi.nlm.nih.gov/pubmed/32445440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2007764
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items